{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:10:32Z","timestamp":1790125832662,"version":"4.0.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T00:00:00Z","timestamp":1532649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"JMI Laboratories"},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/jac\/dky279","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T15:16:13Z","timestamp":1532358973000},"page":"3053-3059","source":"Crossref","is-referenced-by-count":78,"title":["Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015\u201317)"],"prefix":"10.1093","volume":"73","author":[{"given":"Helio S","family":"Sader","sequence":"first","affiliation":[{"name":"JMI Laboratories, North Liberty, IA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Castanheira","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, IA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo E","family":"Mendes","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, IA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K","family":"Flamm","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, IA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,27]]},"reference":[{"key":"key\n\t\t\t\t20181023060156814_dky279-B1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0885066610371189","article-title":"Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind","volume":"25","author":"Arnold","year":"2010","journal-title":"J Intensive Care Med"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/cid\/ciw504","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijantimicag.2014.01.007","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009\u20132012","volume":"43","author":"Sader","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B5","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011\u20132014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/M16-0291","article-title":"Progress in the fight against multidrug-resistant bacteria? A review of U.S. Food and Drug Administration-approved antibiotics, 2010-2015","volume":"165","author":"Deak","year":"2016","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B7","doi-asserted-by":"crossref","first-page":"19.","DOI":"10.1186\/s13054-016-1197-5","article-title":"Treatment of Gram-negative pneumonia in the critical care setting: is the \u03b2-lactam antibiotic backbone broken beyond repair?","volume":"20","author":"Bassetti","year":"2016","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/joim.12342","article-title":"Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control","volume":"277","author":"T\u00e4ngd\u00e9n","year":"2015","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations","volume":"63","author":"van Duin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cmi.2017.09.001","article-title":"New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?","volume":"23","author":"Wright","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B12","doi-asserted-by":"crossref","first-page":"e02252","DOI":"10.1128\/AAC.02252-16","article-title":"Pseudomonas aeruginosa antimicrobial susceptibility results from four years (2012-2015) of the International Network for Optimal Resistance Monitoring program in the United States","volume":"61","author":"Sader","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B14","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing\u2014Twenty-Eighth Edition: M100Ed28","author":"Clinical and Laboratory Standards Institute","year":"2018"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B15","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically\u2014Eleventh Edition: M07Ed11","author":"Clinical and Laboratory Standards Institute","year":"2018"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B16","author":"EUCAST"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B17","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1056\/NEJMra0904124","article-title":"Hospital-acquired infections due to Gram-negative bacteria","volume":"362","author":"Peleg","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B18","author":"National Healthcare Safety Network"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B19","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/320183","article-title":"Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997\u20131999)","volume":"32","author":"Gales","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20181023060156814_dky279-B20"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/11\/3053\/26144738\/dky279.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T01:23:30Z","timestamp":1571621010000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/11\/3053\/5060374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,27]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,7,27]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky279","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733715313.793555341","asserted-by":"object"}]},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,7,27]]}}}